There has been dramatic growth in the number of intravitreal injections performed annually. This paper features expert panel consensus regarding the use of intravitreal injections and serves as an ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

We report a case of posterior lens nucleus displacement following an intravitreal injection of bevacizumab (IVB). To the best of our knowledge this complication has not been previously reported. A ...

Please provide your email address to receive an email when new articles are posted on . Intravitreal injections have a large environmental impact, estimated to be around 210 million kg of CO 2 ...

The use of intravitreal vascular endothelial growth factor (VEGF) inhibitor medications has widened considerably to include indications affecting females of reproductive age. All our patients were ...

Povidone-iodine is the most commonly used antiseptic for the ocular surface. It is also used for the prophylaxis of infection in eyes undergoing intravitreal injection. Published endophthalmitis rates ...

An intravitreal implant (OTX-TKI) containing the tyrosine kinase inhibitor axitinib (Inlyta) was well tolerated and significantly reduced injection frequency by nearly 90% in patients with wet ...

Patients completed a questionnaire that assessed the impact of intravitreal injections on quality of life This article is part of MPR’s coverage of the American Academy of Ophthalmology 2019 Meeting, ...

A low risk of adverse safety outcomes was observed in anti–vascular endothelial growth factor (VEGF) intravitreal injections performed in office-based and operating room settings, with a higher rate ...

Eyepoint Pharmaceuticals (NASDAQ:EYPT) outlined late-stage clinical progress for its lead retinal candidate DURAVYU and ...

In a first of its kind study, Mount Sinai researchers are using optimal coherence tomography angiography (OCTA) to measure potential retina damage from long-term use of intravitreal eye injections.